Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Aktie
?
0,00 %
Überwältigendes Buy-Interesse für Ultragenyx Pharmaceutical Inc.: 26 Buy-Einschätzungen ohne eine einzige Sell-Einschätzung.
Ein Kursziel von 57 € für Ultragenyx Pharmaceutical Inc. würde den aktuellen Kurs von 20.6 € signifikant übertreffen.
